Clinical Trial Update: Percutaneous Administration of Sirolimus in the Treatment of Superficial Complicated Vascular Anomalies [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating percutaneous sirolimus for superficial complicated vascular anomalies, including Kaposiform Hemangioendothelioma and tu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kaposiform Hemangioendothelioma
• Superficial Lymphatic Malformations
• Superficial Vascular Anomalies
• Tufted Angioma

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: Children's Hospital of Fudan University | Conditions: Kaposiform Hemangioendothelioma, Tufted Angioma | Phase 4 | Status: UNKNOWN